0001209191-18-052229.txt : 20180925
0001209191-18-052229.hdr.sgml : 20180925
20180925204825
ACCESSION NUMBER: 0001209191-18-052229
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180925
FILED AS OF DATE: 20180925
DATE AS OF CHANGE: 20180925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pivotal bioVenture Partners Fund I, L.P.
CENTRAL INDEX KEY: 0001695076
STATE OF INCORPORATION: E9
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181086708
BUSINESS ADDRESS:
STREET 1: CODAN TRUST COMPANY (CAYMAN) LIMITED
STREET 2: CRICKET SQ., HUTCHINS DR., GEORGE TOWN
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1111
BUSINESS PHONE: (345) 949 1040
MAIL ADDRESS:
STREET 1: CODAN TRUST COMPANY (CAYMAN) LIMITED
STREET 2: CRICKET SQ., HUTCHINS DR., GEORGE TOWN
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1111
FORMER NAME:
FORMER CONFORMED NAME: Pivotal Venture Partners Fund I, L.P.
DATE OF NAME CHANGE: 20170118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pivotal bioVenture Partners Fund I U.G.P., Ltd
CENTRAL INDEX KEY: 0001752847
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181086709
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: (415) 697-1002
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pivotal bioVenture Partners Fund I G.P., L.P.
CENTRAL INDEX KEY: 0001752862
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181086710
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: (415) 697-1002
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001724344
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824592913
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 810-0120
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Entasis Therapeutics Ltd
DATE OF NAME CHANGE: 20171204
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-09-25
0
0001724344
Entasis Therapeutics Holdings Inc.
ETTX
0001695076
Pivotal bioVenture Partners Fund I, L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
0001752862
Pivotal bioVenture Partners Fund I G.P., L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
0001752847
Pivotal bioVenture Partners Fund I U.G.P., Ltd
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
Series B-1 Tranche A Convertible Preferred Stock
Common Stock
7446904
I
See Footnote
Series B-1 Tranche B Convertible Preferred Stock
Common Stock
9502249
I
See Footnote
Each share of Series B-1 Tranche A Convertible Preferred Stock and Series B-1 Tranche B Convertible Preferred Stock is convertible at any time, at the option of the holder, into Common Stock, on a 20.728-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). Pivotal bioVenture Partners Fund I G.P., L.P. ("Pivotal GP") is the general partner of Pivotal. Pivotal bioVenture Partners Fund I U.G.P., Ltd ("Ultimate General Partner") is the general partner of Pivotal GP. Richard Coles, Peter Bisgaard and Vincent Sai Sing Cheung are directors of the Ultimate General Partner and may, along with the Ultimate General Partner, be deemed to have shared voting and dispositive power over the shares owned by Pivotal.
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Christian Plaza, Attorney-in-Fact
2018-09-25
/s/ Christian Plaza, Attorney-in-Fact
2018-09-25
/s/ Christian Plaza, Attorney-in-Fact
2018-09-25
EX-24.3_810775
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
(For Executing Form ID and Forms 3, 4 and 5)
Know all by these presents, that the undersigned hereby constitutes and
appoints each of Christian Plaza and Jason Minio of Cooley LLP, and Michael
Gutch and Mary Stack of Entasis Therapeutics Holdings Inc. (the "Company"),
signing individually, the undersigned's true and lawful attorneys-in fact and
agents to:
(1) Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission (the "SEC"), a Form ID and
Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in
connection therewith) in accordance with Section 16 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, in the
undersigned's capacity as an officer, director or beneficial owner of more than
10% of a registered class of securities of the Company;
(2) Do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to prepare and execute any such Form ID and Forms
3, 4 or 5 (including amendments thereto and joint filing agreements in
connection therewith) and file such forms with the SEC and any stock exchange,
self-regulatory association or any similar authority; and
(3) Take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required of the undersigned, it being
understood that the documents executed by the attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as the attorney-in-fact may approve in the
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, and their
substitutes, in serving in such capacity at the request of the undersigned, are
not assuming (nor is the Company assuming) any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the Company and the foregoing attorneys-in fact or (c) as to any
attorney-in-fact individually, until such attorney-in-fact is no longer employed
by the Company or employed by or a partner at Cooley LLP or another law firm
representing the Company, as applicable.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.
Date: August 8, 2018
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.
By: /s/ Rob Hopfner
Name: Rob Hopfner
Title: Managing Partner
Date: August 8, 2018
PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.
By: /s/ Rob Hopfner
Name: Rob Hopfner
Title: Managing Partner
Date: August 8, 2018
PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD
By: /s/ Rob Hopfner
Name: Rob Hopfner
Title: Managing Partner